Results 341 to 350 of about 1,198,663 (392)

Clinicopathological features and genomics of ER-positive/HER2-negative breast cancer relapsing on adjuvant abemaciclib. [PDF]

ESMO Open
Corti C, Martin AR, Kurnia PT, Gómez Tejeda Zañudo J, Abravanel DL, Hughes ME, Parker T, Tarantino P, Curigliano G, King TA, Mittendorf EA, Lin NU, Tolaney SM.   +12 more
europepmc   +1 more source

Chitosan, Gelatine, and Cellulose Based Hydrogels for the Removal of Potentially Toxic Elements from Aquaculture Water: A Comparative Study

Advanced Sustainable Systems, EarlyView.
Hydrogels made of chemically modified biopolymers are easy to prepare and cost‐effective, they have proven to be effective materials for the simultaneous removal of seven potentially toxic elements (PTEs) from ultrapure and real water samples. The cellulose‐based one seems the best for single treatments while the gelatine‐based one seems the most ...
Monica Rigoletto, Rossella Sesia, Silvia Berto, Paola Calza, Marco Sangermano, Enzo Laurenti, Mery Malandrino   +6 more
wiley   +1 more source

Prognostic Significance of Delays in Initiation of Adjuvant Trastuzumab-Based Therapy in Patients with HER2-Positive Breast Cancer. [PDF]

Biomedicines
Dowling GP, Hegarty A, Daly GR, Hembrecht S, Hehir CM, Calpin GG, Hogan R, O'Reilly D, Downey E, Toomey S, Grogan L, Breathnach O, Allen M, Morris PG, Power C, Young LS, Hill ADK, Hennessy BT.   +17 more
europepmc   +1 more source

Factors Driving Battery and Solar Purchase Decision of Residents: a Behavioural Choice Experiment Using a Hybrid Discrete Choice and Latent Variable Model

Advanced Sustainable Systems, EarlyView.
This article explores what drives households to adopt solar PV and battery systems in South East Queensland. Using hybrid discrete choice experiments, it reveals distinct adopter profiles and highlights cost, system size, and energy independence as key motivators.
Mohammad Alipour, Elnaz Irannezhad, Rodney A. Stewart, Oz Sahin   +3 more
wiley   +1 more source

Adjuvant chemotherapy may have no significant survival benefit in older patients with stage II/III gastric cancer: a multicenter retrospective study. [PDF]

J Cancer Res Clin Oncol
Shen ZZ, Li EZ, Zhang RL, Cao MX, Zhang YQ, Yang Q, Hu C, Pan SW, Xu ZY, Ye ZS, He JY.   +10 more
europepmc   +1 more source

Environmental Impacts and Cost Analysis of Perovskite Nanocrystals for Light‐Emitting Diode Applications

Advanced Sustainable Systems, EarlyView.
CsPbBr₃ colloidal nanocrystals synthesized via hot‐injection (HI) and microwave‐assisted (MW) methods exhibit excellent optoelectronic properties for LEDs. Although the MW route is more energy‐efficient and eco‐friendly in the lab, industrially, its environmental impacts are similar, but with lower costs.
Jaume‐Adrià Alberola‐Borràs, Thais Caroline Almeida da Silva, Iván P. Franco, Rafael S. Sánchez, Beatriz Julián‐López, Iván Mora‐Seró, Rosario Vidal   +6 more
wiley   +1 more source

Is One Year Enough? Extended Adjuvant Dabrafenib Plus Trametinib for Chinese Patients With Resected Stage III Melanoma. [PDF]

J Dermatol
Jia DD, Xu Y, Ren ZW, Li LQ, Zhang L, Li Y, Lou LS, Yao WT, Liu Z, Li XA, Yang JL, Chen Y, Li T.   +12 more
europepmc   +1 more source

Adjuvant Radiotherapy for Intermediate-Risk Early-Stage Cervical Cancer Post Radical Hysterectomy: A Systematic Review and Meta-Analysis. [PDF]

J Clin Med
da Silva PHCM, Molino GOG, Dias MMF, Pereira AGA, Pimenta NDS, Cavalcante DVS, de Farias Santos ACF, Ferreira SH, da Silva Santos R, da Silva Reis AA.   +9 more
europepmc   +1 more source

Therapeutic Indications of Pembrolizumab in Eight Common Cancers: Current Evidence and Future Directions. [PDF]

Cancer Rep (Hoboken)
Mansour R, Shreba A, Khaddour K, Georgeos M, Alshehabi Z.   +4 more
europepmc   +1 more source

Clinicopathological factors <i>vs</i>. molecular model for predicting adjuvant EGFR-TKI benefit in stage I EGFR-mutant non-small cell lung cancer. [PDF]

Transl Lung Cancer Res
Jiang Y, Lin Y, Fu W, Jiang S, Hao Z, Liang H, He Q, Cheng R, Li B, Deng H, Li C, Li J, Xiong S, Zhong R, Chen S, Wang W, He J, Liang W.   +17 more
europepmc   +1 more source